Actively Recruiting
Benefits of ADHD Treatment in Detained People
Led by Stéphanie Baggio · Updated on 2026-03-17
150
Participants Needed
1
Research Sites
199 weeks
Total Duration
On this page
Sponsors
S
Stéphanie Baggio
Lead Sponsor
U
University of Lausanne
Collaborating Sponsor
AI-Summary
What this Trial Is About
Attention deficit hyperactivity disorder (ADHD) is characterized by difficulties paying attention, poor impulse control, and hyperactive behaviors. It is associated with several health and social detrimental outcomes and leads to increased risks of criminality and recidivism. However, to date, ADHD treatment has been neglected in prison. This project will test the efficacy of ADHD treatment using a randomized controlled trial.
CONDITIONS
Official Title
Benefits of ADHD Treatment in Detained People
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 65 years
- Good command of French
- Expected stay in prison of approximately 4 months at eligibility visit
- Clinical diagnosis of ADHD according to DSM-5 criteria
- Provided written informed consent
You will not qualify if you...
- Presence of an acute uncontrolled psychiatric disorder
- Medical contraindication to stimulant medication
- Potential adverse interaction with another medication
- Currently receiving ADHD treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Geneva University Hospitals
Geneva, Canton of Geneva, Switzerland, 1211
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here